• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.

作者信息

Burmeister Thomas, Ströh Aeint-Steffen, Kehden Britta, Trautmann Heiko, Meyer Claus, Marschalek Rolf, Larghero Patrizia, Schwartz Stefan, Steffen Björn, Spriewald Bernd, Heinicke Thomas, Jäkel Nadja, Westermann Jörg, Nachtkamp Kathrin, Viardot Andreas, Topp Max S, Neumann Martin, Baldus Claudia D, Gökbuget Nicola, Brüggemann Monika

机构信息

Department of Hematology, Oncology and Tumor Immunology, CVK, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.

出版信息

Leukemia. 2024 Jul;38(7):1600-1603. doi: 10.1038/s41375-024-02209-7. Epub 2024 Mar 22.

DOI:10.1038/s41375-024-02209-7
PMID:38519799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11216977/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2090/11216977/3ae007e532da/41375_2024_2209_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2090/11216977/b5022ad7c81e/41375_2024_2209_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2090/11216977/3ae007e532da/41375_2024_2209_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2090/11216977/b5022ad7c81e/41375_2024_2209_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2090/11216977/3ae007e532da/41375_2024_2209_Fig2_HTML.jpg

相似文献

1
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.KMT2A重排的成人急性淋巴细胞白血病患者中可测量残留病的定量分析
Leukemia. 2024 Jul;38(7):1600-1603. doi: 10.1038/s41375-024-02209-7. Epub 2024 Mar 22.
2
Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in -rearranged acute lymphoblastic leukemia: a case report and review of the literature.重排急性淋巴细胞白血病患者接受抗CD19靶向免疫治疗后发生急性髓系白血病不良事件的风险增加：一例报告及文献复习
Leuk Lymphoma. 2019 Jul;60(7):1827-1830. doi: 10.1080/10428194.2018.1562185. Epub 2019 Jan 7.
3
A pediatric case of -rearranged B-lymphoblastic lymphoma treated with high-risk therapy.1例采用高危治疗方案治疗的重排B淋巴细胞淋巴瘤儿科病例。
Leuk Lymphoma. 2024 Jun;65(6):843-847. doi: 10.1080/10428194.2024.2315159. Epub 2024 Feb 19.
4
B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.伴有皮肤受累及KMT2A基因重排的B细胞淋巴母细胞淋巴瘤
Am J Hematol. 2020 Nov;95(11):1427-1429. doi: 10.1002/ajh.25801. Epub 2020 Apr 15.
5
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后频繁 11q23 重排急性白血病的微小残留病监测和抢先免疫治疗。
Ann Hematol. 2021 May;100(5):1267-1281. doi: 10.1007/s00277-021-04488-x. Epub 2021 Mar 13.
6
The role of constitutive activation of FMS-related tyrosine kinase-3 and mutational status in infants with -rearranged acute lymphoblastic leukemia.FMS样酪氨酸激酶-3组成性激活及突变状态在伴有重排的急性淋巴细胞白血病婴儿中的作用
Haematologica. 2017 Nov;102(11):e438-e442. doi: 10.3324/haematol.2017.169870. Epub 2017 Aug 24.
7
Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.急性淋巴细胞白血病中ATP5L-KMT2A的重排
Br J Haematol. 2021 Mar;192(6):e139-e144. doi: 10.1111/bjh.17265. Epub 2020 Dec 13.
8
Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.KMT2A 重排 B 急性淋巴细胞白血病的多谱系累及：起始细胞、生物学和临床意义。
Histopathology. 2024 Aug;85(2):310-316. doi: 10.1111/his.15203. Epub 2024 Apr 30.
9
Extramedullary relapse of ()-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab.在使用博纳吐单抗后，伴有谱系转换的（）重排急性淋巴细胞白血病的髓外复发
Blood. 2018 May 31;131(22):2507. doi: 10.1182/blood-2018-02-834911.
10
Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report.早期T细胞前体急性淋巴细胞白血病伴t(6;11)(q27;q23)/KMT2A-AFDN易位在诱导化疗期间向急性髓系白血病的谱系转换：一例报告
Leuk Res. 2022 Jan;112:106758. doi: 10.1016/j.leukres.2021.106758. Epub 2021 Nov 25.

本文引用的文献

1
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.基因改变和微小残留病优化成人KMT2A重排B细胞前体急性淋巴细胞白血病的风险评估：一项GRAALL研究
Blood. 2023 Nov 23;142(21):1806-1817. doi: 10.1182/blood.2023021501.
2
MRD in adult Ph/BCR-ABL-negative ALL: how best to eradicate?成人 Ph/BCR-ABL 阴性 ALL 中的微小残留病灶：如何最好地清除？
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):718-725. doi: 10.1182/hematology.2021000224.
3
Clinical Implications of Minimal Residual Disease Detection in Infants With -Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol.
《基于 Interfant-06 方案治疗伴有 - 重现性急性淋巴细胞白血病婴儿患者中微小残留病灶检测的临床意义》。
J Clin Oncol. 2021 Feb 20;39(6):652-662. doi: 10.1200/JCO.20.02333. Epub 2021 Jan 6.
4
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies.急性淋巴细胞白血病中的微小残留病诊断：对灵敏、快速且标准化技术的需求。
Blood. 2015 Jun 25;125(26):3996-4009. doi: 10.1182/blood-2015-03-580027. Epub 2015 May 21.
5
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.婴儿MLL重排急性淋巴细胞白血病的体细胞突变图谱。
Nat Genet. 2015 Apr;47(4):330-7. doi: 10.1038/ng.3230. Epub 2015 Mar 2.
6
Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.在MLL重排的人类急性淋巴细胞白血病中鉴定CD34 +和CD34 -白血病起始细胞。
Blood. 2015 Feb 5;125(6):967-80. doi: 10.1182/blood-2014-03-563304. Epub 2014 Dec 23.
7
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.在成人急性淋巴细胞白血病患者中，oncogenetics 和微小残留病是独立的预后预测因素。
Blood. 2014 Jun 12;123(24):3739-49. doi: 10.1182/blood-2014-01-547695. Epub 2014 Apr 16.
8
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.急性淋巴细胞白血病伴分子学复发的成年患者预后不良，是干细胞移植和靶向治疗的候选人群。
Blood. 2012 Aug 30;120(9):1868-76. doi: 10.1182/blood-2011-09-377713. Epub 2012 Mar 22.
9
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.采用Interfant-99方案治疗的急性淋巴细胞白血病婴儿微小残留病的预后意义
Leukemia. 2009 Jun;23(6):1073-9. doi: 10.1038/leu.2009.17. Epub 2009 Feb 12.
10
The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.成人CD10阴性B细胞前体急性淋巴细胞白血病的MLL重组组：来自GMALL研究组的结果。
Blood. 2009 Apr 23;113(17):4011-5. doi: 10.1182/blood-2008-10-183483. Epub 2009 Jan 14.